4.7 Article

Apathy in Parkinson's Disease: Neurophysiological Evidence of Impaired Incentive Processing

期刊

JOURNAL OF NEUROSCIENCE
卷 34, 期 17, 页码 5918-5926

出版社

SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.0251-14.2014

关键词

apathy; feedback-related negativity; Parkinson's disease; incentive processing

资金

  1. Fundacio La Marato de TV3 [060310]
  2. CIBERNED (Fundacion CIEN, Instituto de Salud Carlos III, Spain)

向作者/读者索取更多资源

Apathy is one of the most common and debilitating nonmotor manifestations of Parkinson's disease (PD) and is characterized by diminished motivation, decreased goal-directed behavior, and flattened affect. Despite its high prevalence, its underlying mechanisms are still poorly understood, having been associated with executive dysfunction, and impaired emotional processing and decision making. Apathy, as a syndrome, has recently been associated with reduced activation in the ventral striatum, suggesting that early- to middle-stage Parkinson's disease patients with this manifestation may have a compromised mesocorticolimbic dopaminergic pathway and impaired incentive processing. To test this hypothesis, we measured the amplitude of the feedback-related negativity, an event-related brain potential associated with performance outcome valence, following monetary gains and losses in human PD patients (12 women) and healthy controls (6 women) performing a gambling task. Early-to middle-stage PD patients presenting clinically meaningful symptoms of apathy were compared with nonapathetic PD patients and healthy controls. Patients with cognitive impairment, depression, and other psychiatric disturbances were excluded. Results showed that the amplitude of the feedback-related negativity, measured as the difference wave in the event-related brain potential between gains and losses, was significantly reduced in PD patients with apathy compared with nonapathetic patients and healthy controls. These findings indicate impaired incentive processing and suggest a compromised mesocorticolimbic pathway in cognitively intact PD patients with apathy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report

Saul Martinez-Horta, Clara Naima Marzal-Espi, Silvia Cuso-Garcia, Ignacio Aracil-Bolanos, Jaime Kulisevsky

Summary: A previously healthy woman presented with rapidly progressive neuropsychological deficits, characterized by reduplicative paramnesia and structured visual hallucinations. Initially misdiagnosed as vascular dementia, MRI revealed findings consistent with Heidenhain Variant of Creutzfeldt-Jakob disease.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2023)

Article Pharmacology & Pharmacy

A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease

Josep Gamez, Matilde Calopa, Esteban Munoz, Aileen Ferre, Oscar Huertas, Kevin McAllister, Nuria Reig, Catherine Scart-Gres, Raul Insa, Jaime Kulisevsky

Summary: The aim of this study was to investigate the efficacy and safety of SOM3355 as a repositioned treatment for reducing chorea in Huntington's disease. The results showed that SOM3355 reduced chorea in HD patients and was well-tolerated. Larger studies are needed to confirm its therapeutic utility as an antichoreic drug.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Clinical Neurology

Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson?s disease

Frederic Sampedro, Arnau Puig-Davi, Saul Martinez-Horta, Javier Pagonabarraga, Andrea Horta-Barba, Ignacio Aracil-Bolan, Jaime Kulisevsky

Summary: Cognitive and neuropsychiatric symptoms in Parkinson's disease reflect cortical degeneration, and intracortical diffusivity can detect symptom-specific cortical microstructural damage.

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Letter Clinical Neurology

Theta/Alpha Band Suppression and Clinical Outcomes During Globus Pallidus Internus Deep Brain Stimulation in Huntington's Disease

Saul Martinez-Horta, Ignacio Aracil-Bolanos, Jesus Perez-Perez, Laura Perez-Carasol, Julia Garcia-Cornet, Antonia Campolongo, Juan Angel Aibar-Duran, Rodrigo Rodriguez-Rodriguez, Berta Pascual-Sedano, Jaime Kulisevsky

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Parkinson's Disease-Cognitive Rating Scale (PD-CRS): Normative Data and Mild Cognitive Impairment Assessment in Brazil

Pedro Renato de Paula Brandao, Danilo Assis Pereira, Talyta Cortez Grippe, Diogenes Diego de Carvalho Bispo, Fernando Bisinoto Maluf, Marcia Pereira Yunes, Gilberto Nunes Filho, Candida Helena Lopes Alves, Javier Pagonabarraga, Jaime Kulisevsky, Andressa Matos Luiz da Costa, Cristiano Franco do Val Serafim, Ana Carolina da Bouza Ferreira, Arthur de Melo Monteiro Bastos, Ana Clara Fernandes Belchior, Beatriz Luna Coutinho de Almeida, Brenda Macedo de Almeida e Castro, Matheus Sampaio Matos, Rodrigo Cardoso de Matos, Gabriel de Almeida Rios, Lorena Oliveira Carneiro, Bianca Christie Costa da Mota, Lucas Ernesto do Rego Castro, Vitoria Luisa Silveira Rocha, Maria Clotilde Henriques Tavares, Francisco Cardoso

Summary: This study investigated the reliability, validity, normative data, and accuracy of the PD-CRS for screening PD-MCI in Brazil. The PD-CRS showed good internal consistency and construct validity in the Brazilian context. Age and education level influenced PD-CRS scores, highlighting the importance of considering educational and cultural heterogeneity in cognitive testing.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Divergent cognitive trajectories in early stage Huntington's disease: A 3-year longitudinal study

Saul Martinez-Horta, Jesus Perez-Perez, Javier Oltra-Cucarella, Frederic Sampedro, Andrea Horta-Barba, Arnau Puig-Davi, Javier Pagonabarraga, Jaime Kulisevsky

Summary: There are different types of cognitive decline progression in patients with Huntington's disease, namely a slow progression group and an aggressive progression group. The aggressive group shows a more pronounced loss of functionality and a marked deterioration in motor and psychiatric symptoms.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Geriatrics & Gerontology

Suicidal ideation among people with Parkinson's disease and comparison with a control group

Diego Santos-Garcia, Teresa de Deus Fonticoba, Carlos Cores Bartolome, Maria J. Feal Panceiras, Iago Garcia Diaz, Maria Cristina Iniguez Alvarado, Silvia Jesus, Maria Teresa Boungiorno, Lluis Planellas, Marina Cosgaya, Juan Garcia Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernandez Vara, Iria Cabo, Lydia Lopez Manzanares, Isabel Gonzalez Aramburu, Maria A. Avila Rivera, Victor Gomez Mayordomo, Victor Nogueira, Victor Puente, Julio Dotor Garcia-Soto, Carmen Borrue, Berta Solano Vila, Maria Alvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo Padilla, Juan C. Martinez Castrillo, Pilar Sanchez Alonso, Maria G. Alonso Losada, Nuria Lopez Ariztegui, Itziar Gaston, Jaime Kulisevsky, Marta Blazquez Estrada, Manuel Seijo, Javier Ruiz Martinez, Caridad Valero, Monica Kurtis, Oriol de Fabregues, Jessica Gonzalez Ardura, Ruben Alonso Redondo, Carlos Ordas, Luis M. Lopez Diaz, Darrian McAfee, Pablo Martinez-Martin, Pablo Mir

Summary: This study analyzed the frequency of suicidal ideation and its related factors in Parkinson's Disease patients and compared them with a control group. The results showed no significant differences in suicidal ideation between the two groups. However, depression, poor quality of life, and comorbidity were associated with suicidal ideation.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Review Clinical Neurology

Inhaled levodopa for threatening impending OFF episodes in managing Parkinson's disease

Wolfgang H. Jost, Jaime Kulisevsky, Peter A. LeWitt

Summary: Parkinson's disease (PD) is a neurodegenerative disorder that causes the degeneration of dopaminergic neurons, leading to a wide range of motor and non-motor symptoms. Oral levodopa remains the most effective treatment for symptomatic relief in PD, but over time, motor complications such as Off episodes can occur. Inhaled levodopa powder has been approved as an innovative on-demand therapy to treat Off episodes in PD patients receiving oral levodopa, providing a predictable and fast treatment effect. Clinical studies have shown significant improvement in motor symptoms with the use of inhaled levodopa powder.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Neurosciences

Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease

Andrea Horta-Barba, Saul Martinez-Horta, Frederic Sampedro, Jesus Perez-Perez, Javier Pagonabarraga, Jaime Kulisevsky

Summary: This study aimed to explore the performance and neural correlates of arithmetic deficits in individuals with pre-manifest and early symptomatic Huntington's disease (HD). The results revealed that lower arithmetic performance in HD participants was associated with reduced gray-matter volume and metabolic dysfunction, while in preHD individuals, it was associated with prefrontal alterations. These findings suggest that cognitive deficits in HD involve not only frontal-striatal dysfunctions but also fronto-temporal and parieto-occipital damage.

JOURNAL OF NEUROSCIENCE RESEARCH (2023)

Article Clinical Neurology

A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

Jaime Kulisevsky, Saul Martinez-Horta, Antonia Campolongo, Berta Pascual-Sedano, Juan Marin-Lahoz, Helena Bejr-kasem, Jose L. Labandeira-Garcia, Jose L. Lanciego, Arnau Puig-Davi, Andrea Horta-Barba, Javier Pagonabarraga, Jon Rodriguez-Antiguedad

PARKINSONISM & RELATED DISORDERS (2023)

Review Clinical Neurology

Cerebellar Syndrome Induced by Hypomagnesemia: A Treatable Cause of Ataxia Not to be Missed. Report of Three Cases and a Review of the Literature

Gonzalo Olmedo-Saura, Jesus Perez-Perez, Tomas Xucla-Ferrarons, Roger Collet, Ana Martinez-Viguera, Jaime Kulisevsky

Summary: This study reports three cases of cerebellar syndrome (CS) due to hypomagnesemia, with MRI findings of cerebellar vasogenic edema and symptomatic improvement after magnesium replacement. A literature review of 22 cases showed a subacute onset of symptoms, common encephalopathy and/or epileptic seizures, and MRI findings of vasogenic edema in the cerebellar hemispheres, vermis, or nodule. Early recognition and treatment of hypomagnesemia can avoid recurrences and permanent cerebellar impairment.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Review Clinical Neurology

Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines

Jaime Kulisevsky, Cristian Falup-Pecurariu, Patrick Santens, Wolfgang H. H. Jost

Summary: Managing advanced Parkinson's disease requires education, support, and specialized outpatient care involving various healthcare professionals. Knowledge about existing therapies is important for general neurologists and professionals working with Parkinson's disease patients. Movement disorders specialists and PD nurses play a key role in coordinating a multidisciplinary approach. Access to these therapies remains a challenge, and education and support for stakeholders may improve quality of life.

JOURNAL OF NEURAL TRANSMISSION (2023)

Article Behavioral Sciences

Understanding visual hallucinations: A new synthesis

Daniel Collerton, James Barnes, Nico J. Diederich, Rob Dudley, Dominic Ffytche, Karl Friston, Christopher G. Goetz, Jennifer G. Goldman, Renaud Jardri, Jaime Kulisevsky, Simon J. G. Lewis, Shigetoshi Naral, Claire O'Callaghan, Marco Onofrj, Javier Pagonabarraga, Thomas Parr, James M. Shine, Glenn Stebbins, John-Paul Taylor, Ichiro Tsuda, Rimona S. Weil

Summary: Despite years of research, it remains uncertain why people sometimes perceive things that aren't there. Eight models of complex visual hallucinations have been proposed since 2000, each based on different understandings of brain organization. To address this variability, researchers established an integrated Visual Hallucination Framework that aligns with current theories of veridical and hallucinatory vision, enabling a systematic investigation of the relationship between hallucination phenomenology and cognitive structures. The episodic nature of hallucinations suggests a complex relationship between state and trait markers, highlighting new avenues for research and potential approaches to treating distressing hallucinations.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2023)

暂无数据